Hepatectomy

Hospitals that performed at least 25 major hepatectomies per year had lower rates of postoperative in-hospital mortality and failure to rescue, suggesting better management of postoperative complications.

Nivolumab alone or in combination with ipilimumab was safe and well-tolerated in patients with resectable hepatocellular carcinoma in the perioperative setting, according to a study published in Lancet Gastroenterology and Hepatology.

Treatment with hepatic arterial infusion chemotherapy in combination with sintilimab allowed for surgical resection and produced survival rates similar to lesser advanced hepatocellular carcinoma, according to a presenter at The International Liver Congress.

Cirrhosis, also known as stage 4 fibrosis, is a late stage of scarring in the liver that can result from many chronic liver diseases. Currently, cirrhosis care focuses on management to avoid progression and monitoring in cases that may require liver transplantation.

A set of three prediction models for patients who required liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis estimated postoperative surgical risks and long-term survival rates.